GLP-1 price report: the payment terms behind eight providers

The monthly price in a GLP-1 advertisement can mean a one-month charge, a prepaid annual equivalent or a medication fee with clinical care billed separately. Our October 2026 check of eight providers found all three structures. Compare the amount due now, the renewal interval and what is included before comparing the headline number.

This is an original review of public offers checked on October 6, 2026. The eight providers were selected because they appear in our homepage price tracker; they are not a random market sample or a claim to cover every offer. Some are commercial partners, as explained in our funding disclosure. We did not enroll, complete medical intake or test treatment. These observations do not establish individual eligibility, pharmacy quality or treatment outcomes.

The terms behind eight advertised prices

Where two figures appear, semaglutide comes first and tirzepatide second. Brand-name and compounded routes are not interchangeable. These are dated observations, not guaranteed quotes or a lowest-price ranking.

CoreAge: distinguish the actual landing offer

The annual-plan landing page shows starting prices of $79 per month for semaglutide and $129 for tirzepatide. Its footer says displayed prices are based on a 12-month plan paid in full. At those figures, the arithmetic is $948 and $1,548 upfront. The main product pages separately advertise $99 and $149 starting offers. Do not attach the lander's price to the main site's terms, or assume that an annual equivalent is available as a one-month purchase.¹²³ Our CoreAge review explains the offer distinction.

Eden: an old membership calculation no longer fits

The current GLP-1 program comparison lists semaglutide at $99 per month and tirzepatide at $129. Its FAQ says there is no separate membership fee or required long-term contract, and its month-by-month comparison repeats the same prices. Adding the previously advertised $99 membership to this current offer would overstate the checked price. This illustrates why a price check needs the actual current program page rather than an old snippet.⁴ See the Eden review for scope, limitations and regulatory context.

Trimi and Shed: plan labels need the terms beside them

Trimi lists monthly semaglutide at $175 and tirzepatide at $235. Annual equivalents of $99 and $125 require $1,188 and $1,500 paid upfront. Its six- and twelve-month plans do not auto-renew; the shorter recurring plans do. A person comparing flexibility should record renewal behavior as well as the total.⁵⁶

Shed's one-month price tier lists $199 for semaglutide and $299 for tirzepatide, while its terms describe a two-month minimum. The product-page label alone therefore does not establish a one-month commitment. Read the cancellation window and refund restrictions before payment.⁷⁸⁹ The Shed review and cancellation guide explain the questions to ask.

Sesame: separate the care bill from the prescription

Success by Sesame's $59 monthly care equivalent requires an annual plan. The shorter care option is $99, with the billing FAQ specifying every 28 days. Medication is additional and depends on product, dose, eligibility and pharmacy. The Wegovy pill entry price of $149 applies to the listed lower doses; it is not the combined cost of care and medication.¹⁰

Do not compare Sesame's care fee with another program's medication-inclusive quote. Record both payments and their schedules. Our billing guide shows why 28-day charges also require different annual arithmetic from calendar-month charges.

HealthRX and Sprout: introductory and calendar differences

HealthRX's monthly semaglutide offer moves from $149 initially to $165 at renewal, while tirzepatide moves from $193 to $214. Its prepaid figures of $1,163 and $2,123 cover 48 weeks, with renewal every 12 months. Supply duration and renewal timing are different facts: do not silently turn 48 weeks into a full calendar year of medication.¹¹¹²

Sprout's homepage lists semaglutide at $149 and tirzepatide at $199 every four weeks. It also lists annual plans at $1,188 and $1,788 upfront, while a separate landing page advertises $299 and $349 monthly offers. These belong to different public offers. The Sprout review keeps the distinctions visible rather than choosing whichever number looks cheapest.¹³¹⁴

MadeMed: the divided price is not the payment

MadeMed's injectable semaglutide is $239 per month on the quarterly option, billed $717 every three months. Injectable tirzepatide is $399 per month, billed $1,197 quarterly. The six-month options show $199 and $369 equivalents, billed $1,194 and $2,214. Those larger payments matter to someone who is unsure about staying with a program. The pages also specify a $39 doctor-visit deduction from the refund if treatment is not prescribed.¹⁵¹⁶

The provider separately advertises sublingual products; their prices and evidence should not be substituted for injectable or FDA-approved branded oral products. Shipping frequency also needs its own confirmation. A quarterly payment does not by itself prove that three months of medication arrive together.

How to use this report

• Save the exact offer URL, medication and formulation with the date you checked it.
• Record the amount charged today and at the next renewal, including care or membership fees.
• Record the covered supply separately from the billing interval and shipment schedule.
• Confirm minimum commitment, cancellation deadline and what happens to an already processed prescription.
• Ask for written clarification when two public pages disagree; leave the comparison unresolved until the selected offer is clear.

This report preserves an October 2026 observation. The linked provider reviews and price tracker may contain later checks. Compounded medications are not FDA-approved, and public price verification is not clinical endorsement. No numerical average is presented because these offers differ in route, fees, dose conditions, supply and commitment.